Beacon Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$6.33M Buy
52,153
+4,039
+8% +$486K 1% 39
2016
Q4
$5.55M Sell
48,114
-1,997
-4% -$222K 0.91% 41
2016
Q3
$5.24M Sell
50,111
-760
-1% -$79.3K 0.88% 47
2016
Q2
$4.96M Buy
50,871
+1,001
+2% +$94.6K 0.84% 49
2016
Q1
$4.79M Buy
49,870
+3,622
+8% +$330K 0.83% 49
2015
Q4
$4.19M Buy
46,248
+2,163
+5% +$204K 0.73% 53
2015
Q3
$4.09M Sell
44,085
-360
-0.8% -$34.2K 0.72% 50
2015
Q2
$4.14M Buy
44,445
+2,704
+6% +$252K 0.67% 51
2015
Q1
$3.95M Buy
41,741
+14,663
+54% +$1.36M 0.6% 54
2014
Q4
$2.4M Buy
27,078
+1,378
+5% +$117K 0.37% 75
2014
Q3
$2.06M Buy
+25,700
New +$1.94M 0.34% 83

Other funds holding CME

Beacon Trust's CME Position: Q1 2017 in Review

Beacon Trust increased its CME Group (CME) stake by 8.4% in Q1 2017, buying an estimated $486K and bringing the position to 52,153 shares worth $6.33M. The position accounts for 1% of the portfolio, ranked #39.

Beacon Trust first reported a position in CME in Q3 2014 and has held it in 11 quarters since. 763 funds tracked by Wall St. Rank hold CME as of Q1 2017.

  • Beacon Trust held 52,153 shares of CME Group worth $6.33M as of Q1 2017.
  • Beacon Trust bought 4,039 CME Group shares in Q1 2017, an estimated $486K.
  • CME Group made up 1% of Beacon Trust's portfolio in Q1 2017, its #39 holding.
  • Beacon Trust first reported a position in CME Group in Q3 2014 and has held it in 11 quarters since.
  • 763 funds tracked by Wall St. Rank held CME Group as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.